Nirsevimab for the Prevention of RSV in Infants
Register Here Space is limited. There is no cost for this event.
Join us for a presentation on RSV Bunden in infants, Nirsevimab characteristics, clinical development and implementation of policy. Q&A will follow presentation.
Event Details:
Date: April 3rd, 2024
Check-in: 6pm. Presentation starts promptly at 6:30pm.
Speaker: Morgan Anderson, PharmD, BCIDP, Medical Science Liaison
Location: Beatrix, 155 N. Wacker Drive Suite 100 | Chicago, IL 60606*
Dinner will be provided.
*No Valet is available at this location
Disclaimer: This program is non-promotional and sponsored by Sanofi US. The content contained in this presentation is not eligible for continuing education credit (CME).
Virtual Vinyasa Flow Yoga
This event benefits The Colette Louise Tisdahl Foundation, working to improve outcomes of pregnancy, childbirth, infancy, prematurity as well as assist with the impact of loss through financial assistance, education, and advocacy.